| Ytd | -57.68% | |
| 1y | -85.58% |
| Open | 3.75 | Prev Close | 3.88 | Low | 3.70 | High | 3.84 | Mkt Cap | 724.11K |
| Vol | 34.29K | Avg Vol | 2.23M | EPS | -61.75 | P/E | -0.06 | Forward P/E | -1.01 |
| Beta | 1.35 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.45 | 200-d Avg | 7.44 | 1yr Est | 20.00 |
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
Dear Fellow Shareholders,Following several significant developments in recent weeks, I wanted to pro
Fiscal 2026 Annual Report, filed July 2, 2026, reflects cash of $6.4 million, total assets of $8.3 m
LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares j
Dow Jones up 0.1%, Nasdaq up 0.07%, S&P 500 up 0.11%. Communication services up 0.9% and Health
Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX) announced today
LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq:
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular
Virax Biolabs (VRAX) shares exploded higher on Thursday morning after management announced a lucrati
U.S. stocks higher, Dow gains over 150 points. NASDAQ up 0.84%, S&P 500 up 0.60%. Tech shares ju
Virax Biolabs Group Limited (NASDAQ:VRAX) stock is up during Thursday's premarket session, as the co
Virax Biolabs signs a Southeast Asia supply deal with Fosun Diagnostics, expanding ImmuneSelect sale
US stocks mixed, Nasdaq up 0.46% as Dow drops 0.06%. Tech shares surge 1.4%, consumer staples fall 1
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's
Virax Biolabs Group Limited (NASDAQ:VRAX) ("Virax" or the "Company") today announced
LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Com
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announce
LONDON, June 24, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Co
LONDON, May 26, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Com
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
Virax Biolabs is advancing a focused strategy centered on ViraxImmune™ and a U.S. market-entry pathw
Bloom Energy (BE) rose in pre-market trading as it announces expanded partnership with Oracle (ORCL)
US stocks fall, Dow down 350 points, tech up 1.2%. Goldman Sachs beats earnings, oil up 7.1%, Europe
IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline
Virax Biolabs said that Virax Biolabs (UK) Limited, its wholly owned subsidiary, has achieved ISO 13